This page shows the latest Ernst and Young news and features for those working in and with pharma, biotech and healthcare.
The latest Beyond Borders report from Ernst &Young has plenty of positive and negative news, but on balance concludes the industry had a good year. ... such as "understanding consumer behaviour, brand building, big data analysis, IT and short-cycle
Ernst &Young, Abbott and McKinsey. ... in difficult times, their tips on how to get ahead, and the important things to focus on.
Extent of biotech's vulnerability revealed. A global survey of the biotech industry conducted by Ernst &Young has confirmed that the global financial crisis has adversely affected the capital invested in ... A global survey of the biotech industry
The role of marketing in both clinical trial activity and post-marketing studies. ... industry. The author. John Smart is a partner at Ernst &Young, Forensic Investigations and Dispute Advisory Services.
Patent expirations:In 2005, Ernst &Young reported that USD 23bn worth of products lost patent protection, representing the highest ever dollar value recorded. ... Ernst &Young reported that the collective market capitalisation of the top 360 public
More from news
Approximately 0 fully matching, plus 5 partially matching documents found.
Ernst and Young in its report Beyond Borders also reports declines in volumes of M&A and strategic alliance deals in 2016. ... This referred to the CAR-T therapy, Kymriah, from Novartis for treating a form of acute lymphoblastic leukaemia in children and
Pharmacyclics filled the bill. Table 1: Company and product acquisition deals in March. ... In 2014 according to Ernst and Young's report Firepower fireworks the aggregate value of biopharma deals in 2014 was over $200bn compared to around $80bn the year
More from intelligence
Approximately 0 fully matching, plus 2 partially matching documents found.
Kirkland previous positions at Ernst and Young, BT, Pearson and was most recently chief financial officer for life sciences consultancy Kinapse. ... Dennis said: “Jenifer’s experience and leadership will be invaluable to scaling up our finance
Chase adds former Allergan execs to leadership team. Scott Giacobello and Gary Charbonneau join. ... Most recently, Giacobello served as vice president of finance for global research and development at Allergan, and has held financial positions at Black
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
BASTARD . LONDON collaborates with you to amplify brand ideas into a visual brand language that resonates and engages with...